Health
SFRP2 and PD-1 immunotherapy combination halts osteosarcoma metastasis in model – EurekAlert
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist…
IMAGE: Hollings Cancer Center researcher Nancy Klauber-DeMore, M.D., is leading the first breakthrough in pediatric osteosarcoma treatment in decades.
view more
Credit: MUSC Hollings Cancer Center/Marquel Coaxum
In a cancer that has not seen new targeted…
Continue Reading